Posts Posts by: "Tim Fell"

LONDON, 11 February 2015 – British bioengineering firm Synthace has closed a £2.2 million funding round with new investors SOSventures, Bioeconomy Capital and Rainbow Seed Fund joining Sofinnova Partners and other existing investors. Synthace develops and applies bioengineering tools and working practices, working with industry leaders to accelerate the introduction of bio-based products into…(Read More)

Antha is a language developed at Synthace to enable the rapid development, execution, and analysis of complex biological experiments.  Synthace is now releasing this language to the global community so that everyone can benefit from robust, reproducible and shareable biological experimentation. Antha elements are not locked into equipment from any single manufacturer, and can be…(Read More)



As part of our commitment to innovate responsibly Synthace scientists all adhere to the code of ethics for researchers drawn up by the UK government’s chief scientific advisor, Sir David King. The seven principles of the code are: Act with skill and care in all scientific work. Maintain up to date skills and assist…(Read More)

At Synthace we have a strong focus on Responsible Innovation (RI). In particular, we seek to assess, prioritise and effectively manage the social, ethical and environmental impacts of our technologies, the risks and opportunities, both now and in the future. Specifically, we use a framework that addresses the following: What is novel in what we…(Read More)